Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Astressin-B can reverse and prevent hair loss in stressed mice.

The treatment was ineffective in humans.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Midazolam's seizure prevention is partly due to increased neurosteroid production.

Certain Dibenzo derivatives may help treat prostate cancer.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

SIG-1451 could be a promising new treatment for atopic dermatitis.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

A3B5 can reduce skin pigmentation and slow melanoma growth.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

AH-001 could be a safer and more effective treatment for hair loss.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.